Rapid Micro Biosystems, Inc.
RPID
$2.22
$0.020.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.28M | 7.84M | 7.26M | 7.21M | 8.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.28M | 7.84M | 7.26M | 7.21M | 8.22M |
| Cost of Revenue | 11.61M | 7.14M | 6.99M | 6.80M | 7.24M |
| Gross Profit | -328.00K | 696.00K | 275.00K | 404.00K | 981.00K |
| SG&A Expenses | 8.66M | 8.54M | 9.19M | 8.44M | 7.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.49M | 19.21M | 19.41M | 18.87M | 18.45M |
| Operating Income | -12.21M | -11.37M | -12.15M | -11.66M | -10.23M |
| Income Before Tax | -12.48M | -11.50M | -11.85M | -11.26M | -9.68M |
| Income Tax Expenses | 14.00K | 8.00K | 11.00K | 7.00K | -9.00K |
| Earnings from Continuing Operations | -12.50M | -11.51M | -11.86M | -11.26M | -9.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.50M | -11.51M | -11.86M | -11.26M | -9.67M |
| EBIT | -12.21M | -11.37M | -12.15M | -11.66M | -10.23M |
| EBITDA | -11.62M | -10.67M | -11.44M | -10.91M | -9.46M |
| EPS Basic | -0.28 | -0.26 | -0.27 | -0.26 | -0.22 |
| Normalized Basic EPS | -0.17 | -0.16 | -0.17 | -0.16 | -0.14 |
| EPS Diluted | -0.28 | -0.26 | -0.27 | -0.26 | -0.22 |
| Normalized Diluted EPS | -0.17 | -0.16 | -0.17 | -0.16 | -0.14 |
| Average Basic Shares Outstanding | 44.62M | 44.96M | 44.65M | 43.99M | 43.77M |
| Average Diluted Shares Outstanding | 44.62M | 44.96M | 44.65M | 43.99M | 43.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |